Literature DB >> 24199766

Aortic arch rupture after multiple multilayer stent treatment of a thoracoabdominal aneurysm.

Emanuele Ferrero1, Lorenzo Gibello2, Michelangelo Ferri2, Andrea Viazzo2, Franco Nessi2.   

Abstract

Despite the improvement in diagnostic and therapeutic strategies, the treatment of thoracoabdominal aneurysms is still burdened with a high incidence of peri/postoperative morbidity and mortality. The multilayer flow modulator is a new and promising technique for the treatment of such disease; however, some limits are still evident. We report the case of a 76-year-old woman affected by a symptomatic thoracoabdominal aneurysm treated with multiple Cardiatis multilayer flow modulators complicated by aortic arch rupture on the fifth postoperative day, with subsequent patient death.
Copyright © 2014 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24199766     DOI: 10.1016/j.jvs.2013.08.006

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

1.  Management of complicated aortic aneurysms using multiple overlapping uncovered stents: mid-term outcome from a cohort study.

Authors:  Yongxue Zhang; Zhongzhao Teng; Qingsheng Lu; Zhiqing Zhao; Junmin Bao; Xiang Feng; Rui Feng; Zengsheng Chen; Yuan Huang; Umar Sadat; Jonathan H Gillard; Zaiping Jing
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

2.  Hemodynamic Study of Flow Remodeling Stent Graft for the Treatment of Highly Angulated Abdominal Aortic Aneurysm.

Authors:  Siang Lin Yeow; Hwa Liang Leo
Journal:  Comput Math Methods Med       Date:  2016-05-09       Impact factor: 2.238

3.  Thoracic endovascular aortic repair with left subclavian artery coverage without prophylactic revascularisation-early and midterm results.

Authors:  J Wojciechowski; L Znaniecki; K Bury; J Rogowski
Journal:  Langenbecks Arch Surg       Date:  2014-04-26       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.